Immediate Impact
60 standout
Citing Papers
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Works of Qianwei Ye being referenced
Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy
2021
Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Qianwei Ye | 238 | 37 | 121 | 208 | 15 | 473 | |
| Pai‐Chi Teng | 231 | 24 | 160 | 211 | 15 | 484 | |
| Jiamin Cheng | 273 | 33 | 152 | 171 | 25 | 481 | |
| Shuzhen Chen | 220 | 37 | 105 | 140 | 13 | 456 | |
| Xin Zhang | 245 | 30 | 184 | 269 | 16 | 507 | |
| Lantian Tian | 293 | 53 | 121 | 211 | 20 | 528 | |
| Manling Huang | 293 | 69 | 132 | 193 | 18 | 510 | |
| Ning Zhang | 249 | 62 | 89 | 215 | 20 | 472 | |
| Nikol Snoeren | 201 | 73 | 224 | 166 | 16 | 511 | |
| Yantao Chai | 269 | 31 | 159 | 202 | 19 | 535 | |
| Minna Shen | 207 | 23 | 200 | 205 | 22 | 501 |
All Works
Login with ORCID to disown or claim papers
Loading papers...